Recently discovered associations of resistin with carotid artery atherosclerosis [32] and markers of chronic renal failure in patients with different levels of GFR and metabolic syndrome confirm the active role of resistin in the manifestation of diffuse atherosclerotic damage [33]. Here, RETN is linked to metabolic syndrome.